Atherosclerotic cardiovascular disease risk in polyendocrine metabolic ovarian syndrome: a nationwide, US, claims-based, retrospective, longitudinal, cohort study

The Lancet Obstetrics, Gynaecology, & Women's Health · Published 2026-07-20 · DOI 10.1016/s3050-5038(26)00090-7

Authors (9)

Snigdha Alur-Gupta, Julia D DiTosto, Jennifer Lewey, Daniel E Soffer, Qing Liu, Kyle R Busse, Colleen Brensinger, Sunni L Mumford, Anuja Dokras

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Alur-Gupta, S., DiTosto, J., Lewey, J., et al. (2026). Atherosclerotic cardiovascular disease risk in polyendocrine metabolic ovarian syndrome: a nationwide, US, claims-based, retrospective, longitudinal, cohort study. The Lancet Obstetrics, Gynaecology, & Women's Health. https://doi.org/10.1016/s3050-5038(26)00090-7

Related articles